ABBVIE 15/35ABBVIE 15/35ABBVIE 15/35

ABBVIE 15/35

No trades
See on Supercharts

Key terms


Outstanding amount
‪2.50 B‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
4.50% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
5.15%
Maturity date
May 14, 2035
Term to maturity
10 years

About ABBVIE 15/35


Sector
Health Technology
Home page
Issue date
May 14, 2015
FIGI
BBG008MXGZX4
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.